Patients who have suffered from the drug Mediator are to be compensated.
The announcement has been made by the company Servier ‘s new president following the death of its founder last month.
Officials in France have blamed at least 500 deaths on the drug which was marketed to overweight diabetics but often prescribed for weight loss.
Get a different perspective
Every story can be told in many ways: see the perspectives from Euronews journalists in our other language teams.